Operating Lease, Right-of-Use Asset of TG THERAPEUTICS, INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TG THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • TG THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,501,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,501,000 -$910,000 -12% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $6,718,000 -$945,000 -12% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $6,927,000 -$979,000 -12% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $7,151,000 -$899,000 -11% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $7,411,000 -$860,000 -10% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $7,663,000 -$812,000 -9.6% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $7,906,000 -$783,000 -9% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $8,050,000 -$838,000 -9.4% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $8,271,000 -$808,000 -8.9% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $8,475,000 -$308,000 -3.5% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $8,689,000 -$275,000 -3.1% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $8,888,000 +$259,000 +3% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $9,079,000 +$275,000 +3.1% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $8,783,000 -$190,000 -2.1% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $8,964,000 -$177,000 -1.9% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $8,629,000 -$683,000 -7.3% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $8,804,000 -$179,000 -2% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $8,973,000 -$168,000 -1.8% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $9,141,000 -$153,000 -1.6% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $9,312,000 -$90,000 -0.96% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $8,983,000 +$490,000 +5.8% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $9,141,000 +$1,482,000 +19% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $9,294,000 +$1,347,000 +17% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $9,402,000 +$9,402,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $8,493,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $7,659,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $7,947,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.